The genotoxicity and systemic toxicity of a pharmaceutical effluent in Wistar rats may involve oxidative stress induction  by Adeoye, Grace O. et al.
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There  is  scarcity  of information  on  the  possible  mechanisms  of pharmaceutical  efﬂuent  induced  geno-
toxicity  and  systemic  toxicity.  This  study  investigated  the genotoxicity  and  systemic  toxicity  of  a
pharmaceutical  efﬂuent  in Wistar  rats.  Rats  were  orally  treated  with  5–50%  concentrations  of  the  efﬂuent
for 28  days.  At  post-exposure,  blood,  liver,  kidney  and  bone  marrow  cells  were  examined  for  alterations  in
serum  biochemical  parameters  and  hematological  indices,  histopathological  lesions  and  micronucleated
polychromatic  erythrocytes  formation  (MNPCE).  The  efﬂuent  caused  concentration  independent  signiﬁ-
cant  (p  <  0.05)  alterations  in aspartate  (AST)  and  alanine  (ALT)  aminotransferases,  superoxide  dismutase
(SOD),  catalase  (CAT),  malondialdehyde  (MDA),  total  and  direct  bilirubin  and  creatinine.  There  was  reduc-
tion in red  blood  count  (RBC),  hemoglobin  concentration  (HGB),  platelets,  percentage  hematocrit  (HCT),
white  blood  count  (WBC)  and  mean  corpuscle  hemoglobin  (MCH)  except  mean  corpuscle  hemoglobin
concentration  (MCHC),  which  increased  in the  treated  rats.  Histopathological  lesions  observed  in  the  liver
and kidney  of  the efﬂuent  treated  rats  were  thinning  of  the  hepatic  cord,  kuffer  cell  hyperplasia,  vacuo-
lation  of the hepatocytes  and  renal  cells,  multifocal  inﬂammatory  changes,  necrosis  and congestion  of
the renal  blood  vessels  and central  vein.  MNPCE  signiﬁcantly  increase  in  the  bone  marrow  of  the treated
rats  compared  to  the negative  control.  The  concentration  of  some  toxic  metals  and  anions  in the  efﬂuent
were  above  standard  permissible  limits.  These  ﬁndings  showed  that  the pharmaceutical  efﬂuent  caused
somatic  DNA  damage  and  systemic  toxicity  in  rats  may  involve  induction  of  oxidative  stress,  suggesting
environmental  contamination  and  health  risks  in  wildlife  and  humans.
©  2015  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
There is unprecedented increase in the pollution status of most
quatic and terrestrial environment worldwide, due mainly to
astewater and solid waste discharge from anthropogenic activ-
ties. Increase in the production and utilization of pharmaceuticals
cross the world have caused the pharmaceutical industry to be one
f the major source of solid wastes and efﬂuent discharge into the
nvironment [1]. Pharmaceuticals are chemicals used for diagnosis,
reatment (cure/mitigation), alteration or prevention of diseases,
ealth condition or structure and function of the body [2]. Solid
astes and efﬂuents generated during pharmaceutical activities
re enormous and diverse due to the use of different chemicals
uring production processes of various drugs. Also, animal pro-
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214-7500/© 2015 Published by Elsevier Ireland Ltd. This is an open access article under license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
duction in many countries is increasing in recent time so as to
provide adequate food required by the increasing human popu-
lation. Achievements in animal farming involve the use of drugs
like antibiotics, food additives, hormones and parasiticides to boost
production. Many of these drugs are excreted as active metabolites
or unmetabolised, while others may  escape being degraded in the
waste treatment plants. These activities along with improper dis-
posal of expired drugs by burning and burying in the soil release
hosts of xenobiotics into the environment [3]. While in the environ-
ment majority of the pharmaceutical products accumulate in water
bodies, aquatic sediments, soil, and biological systems, reaching a
biologically active concentration with time [4,5].
The volume of water used during various drug operational
stages contain numerous chemicals and microorganisms which are
discharged as pharmaceutical efﬂuent into the environment, and
this has been reported to be highly toxic to living organisms mostly
due to the presence of salts, surfactants (such as detergents, emulsi-
ﬁers and dispersants), ionic metals and their metal complexes, toxic
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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rganic chemicals, biocides, unmetabolized drugs, toxic anions and
icroorganisms [4,6,7,8]. In Nigeria, most pharmaceutical indus-
ries located in the cities are known to discharge huge volumes
f untreated efﬂuent directly into the environment [9,10]. This
s enhanced by ignorance on the part of many Nigerians on the
eleterious effects of drugs and many other xenobiotics including
icrobes present in the efﬂuents on environmental degradation
nd public health [6]. Moreover, poor enforcement of stringent reg-
lations prohibiting illegal discharge of efﬂuents is not favoring
nvironmental conservation. There are increasing concerns about
he adverse effects of these efﬂuents on the ecosystem, wildlife
iversity and human health. With respect to this, studies have iden-
iﬁed speciﬁc chemical components in pharmaceutical efﬂuents
o show the deleterious effects on living organisms [3,10,11,12].
his approach has a limitation of providing information on the
oxic effects of all the individual components present as mixture
f xenobiotics in the efﬂuent. Also the potential synergistic and
ntagonistic interactions of these xenobiotics in the living organ-
sms were not considered. Therefore, experimental toxicity studies
ere conducted both in the laboratory and on the ﬁeld to deter-
ine the toxic and genotoxic effects of pharmaceutical efﬂuents as
 complex mixture of xenobiotics [4,7,8], but most of these stud-
es are limited by their inability to provide possible mechanisms
f pharmaceutical efﬂuent induced mutagenicity, genotoxicity and
ystemic toxicity.
Due to the speciﬁc mode of action and the fact that drugs and
harmaceutical compounds are deliberately designed to exert their
ffects on humans, mammals and other vertebrates, the systemic
oxicity and genotoxicity assessment of pharmaceutical efﬂuent
sing mammalian test model will be more relevant in relating ﬁnd-
ngs to human health. Biomarkers of systemic toxicity (biochemical,
istopathological and hematological analyses) in mammals offer
etter understanding of the possible mechanisms of genotoxicity
nd tissue damage in the case of exposure to mixture of xenobiotics
13,14,15,16]. However, until now the mode of action of pharma-
eutical efﬂuents induced genotoxicity in mammalian system is not
ell understood. Many of the components (most importantly toxic
etals) are known to induce oxidative stress as a major mecha-
ism of chemical induced toxicity [17]. Furthermore, the liver and
idney are sensitive predictor of chemical induced toxicity, due to
heir ability to metabolize, detoxify, store and eliminate xenobiotics
nd there metabolites. Hence, they are target organs for xenobiotic
nduced toxicity [18,19]. Hence, the need to understand the possi-
le mechanisms by which pharmaceutical efﬂuent may  induce liver
nd kidney dysfunction, and genotoxicity in mammalian system.
his study investigated the frequency of micronucleated polychro-
atic erythrocytes (MNPCE) formation, histopathological lesions in
he liver and kidney, changes in hematological indices, and alter-
tions in serum antioxidant enzyme activities, lipid peroxidation
nd liver and kidney biochemical function parameters in phar-
aceutical efﬂuent treated Wistar rats. Some physico-chemical
arameters and heavy metal constituents of the efﬂuent were also
nalyzed.
. Materials and methods
.1. Efﬂuent collection and processing, physico-chemical and
eavy metal analyses
Pharmaceutical efﬂuents were collected from a pharmaceutical
ndustry with branches located in Ilupeju, Lagos state and Sango
ta, Ogun state both in Nigeria, into a 10 L transparent plastic con-
ainer. The pH of the efﬂuent was measured before transported to
he laboratory for further processing. An aliquot was analyzed for
 number of standard physical and chemical parameters includ-ports 2 (2015) 1265–1272
ing chemical oxygen demand (COD), total dissolved solids (TDS),
alkalinity, hardness, biochemical oxygen demand (BOD), chlorides,
sulphates, nitrates, ammonia and phosphates in accordance with
the APHA [20]. Seven heavy metals; cadmium (Cd), arsenate (As),
copper (Cu), chromium (Cr), iron (Fe), zinc (Zn), nickel (Ni) and
manganese (Mn) were also analyzed in the efﬂuent in accordance
with standard method [20,21]. 100 ml of the efﬂuent was  digested
by heating with concentrated nitric acid (HNO3). The resulting mix-
ture was  made up to 10 ml  using 0.1 N HNO3. The concentration
of the metals was estimated using PerkinElmer® A3100 atomic
absorption spectrophotometer. Another aliquot was ﬁltered with
glass wool and Whatmann® No. 42 ﬁlter paper to remove sus-
pended particles; centrifuged at 3000 g for 15 min  and stored at
4 ◦C until use for the animal exposure. This was considered as the
stock sample (100%).
2.2. Animals and experimental design
Male Wistar rats (between 8 and 9 weeks old) obtained from the
animal unit, College of Medicine, University of Ibadan, Nigeria, were
acclimatized for 2 weeks in the Department of Zoology, University
of Lagos animal facility until they attained a body weight range of
126.4–161.8 g. They were maintained in laboratory conditions of
12 h dark and light cycle, temperature of 26.9 ± 6 ◦C and had access
to clean drinking water and standard rodent chow (Ladokun feed
Nigeria®) ad libitum. Guide for care and use of laboratory animals
published by the US National Institutes of Health (NIH Publication
No. 85–23, revised in 1996), and approved by the ethical committee,
University of Lagos for the use of animals in experimental stud-
ies was  carefully adhered during the study. 5, 10, 20, 30 and 50%
concentrations (v/v, efﬂuent/distilled water) of the efﬂuent were
selected according to previous study [22], and 0.5 ml was orally
administered daily to each of the ﬁve rats per exposure group for
28 days [15]. Similar treatment was  concurrently given to the neg-
ative (distilled water) and positive (cyclophosphamide 40 mg/kg
body weight) control groups.
2.3. Serum biochemical analysis
At post-exposure, rats were fasted overnight and blood was
collected from the orbital plexus using heparinized 70 ml  micro-
hematocrit capillary tubes into lithium coated serum separator
tubes and EDTA tubes. The clotted blood in the lithium tubes was
centrifuged at 3000 g for 10 min to separate the serum (super-
natant) and stored at −70 ◦C prior to biochemical analysis. Serum
biochemical markers of oxidative stress were measured accord-
ing to standard protocols: Catalase (CAT; EC 1.11.1.6) activity was
measured according to Aebi [23], superoxide dismutase (SOD;
EC 1.15.1.1) activity was measured based on Magwere et al.
[24] method, while lipid peroxidation was  measured as malondi-
aldehyde (MDA) concentrations in accordance with Nichaus and
Samuelson [25]. Protein concentration was measured according to
Lowry et al. [26]. Serum liver and kidney functional test markers;
transaminases were measured according to Reitman and Frankel
[27], total and direct bilirubin according to Treitz [28] and creati-
nine according to Henry et al. [29] using Randox Laboratory (UK)
diagnostic kits. The absorbance for all the reactions were measured
spectrophotometrically using HAICE®, DR 3000 (Germany).
2.4. Haematological analysis
Blood collected into the EDTA bottles was analyzed for the rec-
ommended hemogram: total erythrocyte count (RBC), hemoglobin
content (HGB), percentage hematocrit (HCT), mean corpuscle
hemoglobin concentration (MCHC), mean corpuscle hemoglobin
(MCH), platelets (PLT) and white blood cell count (WBC) [30] using
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Fig. 1. Effects of pharmaceutical efﬂuent on serum ALT and AST activities. End point
represents mean ± SD for 5 rats. Values are signiﬁcantly different *p < 0.05 compared
to  the corresponding negative controls. DW – Distilled Water; CYP – Cyclophos-
phamide (40 mg/Kg bwt).
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Fig. 2. Effects of pharmaceutical efﬂuent on micronuclei polychromatic erythrocyteG.O. Adeoye et al. / Toxicolo
utomated analyzer, (Abbott Hematology Analyzer Cell-Dyn 1700,
bbott Laboratories, Abbott Park, Illinois, USA).
.5. Mammalian bone marrow micronucleus assay
Animals were sacriﬁced by cervical dislocation and the femoral
ones surgically removed for bone marrow micronucleus test
8,31]. The bone marrow was ﬂushed into Eppendorf tubes using
.5 ml  of Fetal Bovine Serum (FBS). The cells were centrifuged at
000 g for 5 min  and smear made on pre-cleaned grease free slides.
lides were air dried and stained with May–Grunwald and Giemsa
tains. They were coded and examined under an Olympus light
icroscope at 1000× magniﬁcation. 2000 cells per rat were scored
or micronucleated polychromatic erythrocyte (MNPCE).
.6. Histopathological analysis
Slices of the right lobe of the liver and right kidney from efﬂuent
reated and control rats were ﬁxed in 10% neutral buffered for-
alin. The tissues were dehydrated in ascending order of ethyl
lcohol–water concentrations, cleared in xylene and sequentially
mbedded in parafﬁn wax blocks using rotary microtome. Tissue
ections of 3–5 m thick were cut and prepared on clean slides for
ematoxylin–Eosin (H–E) staining before mounting in neutral DPX
edium. Prepared slides were examined at 400x magniﬁcation by
rained pathologist.
.7. Statistical analysis
All statistical analyses were conducted with Graphpad prism
.0® computer programs. One-way ANOVA was  used to determine
he differences (p < 0.05) among the various groups. Difference
etween each treatment group and the negative control was deter-
ined using Dunnett multiple post-hoc test (DMPT) procedure at
 < 0.05.
. Results
.1. Heavy metal and physico-chemical characterization of the
fﬂuent
Heavy metals and physico-chemical parameters of the efﬂuent
re presented in Table 1. Fe, Mn  and Cu concentrations in the sam-
le were higher than national and international allowable limits.
d, As, Ni and Cr were below detectable limits. The pH value is
ithin normal range for efﬂuents both in national and international
llowable standards. COD, BOD, phosphate, alkalinity and total dis-
olved solids were above permissible limits while all other analyzed
arameters were below permissible limits.
.2. Biochemical indicators of hepatic function, lipid peroxidation
nd oxidative stress
Results of the antioxidant enzyme activities and lipid peroxida-
ion in the efﬂuent treated rats; SOD and CAT activities, and MDA
oncentration signiﬁcantly (p < 0.05) increase compared to the neg-
tive control. The fold increase in SOD (2.44, 2.34, 3.82, 6.03 and
.25), CAT (1.71, 1.07, 1.07, 6.79 and 7.43) and MDA  (1.97, 1.48,
.26, 1.70 and 5.52) according to the efﬂuent concentrations; 5,
0, 20, 30 and 50%, respectively, was not concentration dependent
Table 2). Serum hepatic function tests: ALT and AST activities, and
irect and total bilirubin concentrations and serum renal function
est: creatinine concentration signiﬁcantly (p < 0.05) increase in the
fﬂuent treated rats compared to the negative control (Fig. 1 and
able 2). The fold increase in AST (1.69, 1.13, 2.51, 2.36 and 3.33),
LT (1.07, 1.20, 1.41, 1.44 and 1.57), DB (1.09, 1.27, 1.82, 1.18 andformation (MNPCE). End point represents mean ± SD for 5 rats. Values are signiﬁ-
cantly different *p < 0.05 compared to the corresponding negative controls. DW –
Distilled Water; CYP – Cyclophosphamide (40 mg/Kg bwt).
1.18), TB (1.65, 1.82, 2.82, 1.41 and 1.24) and creatinine (1.12, 1.31,
1.80, 1.33 and 1.19) according to the efﬂuent concentrations; 5, 10,
20, 30 and 50%, respectively, were not concentration dependent for
all the tested parameters.
3.3. Hematological analysis
The results of the hematological indices showed that RBC, HCT,
HGB, MCH, PLT and WBC  were reduced compared to the negative
control. While this reduction was insigniﬁcant (p > 0.05) for RBC,
HCT, HGB and MCH, it was marginally signiﬁcant (p < 0.05) for PLT
and WBC. Only MCHC increased in the efﬂuent treated rats but
was insigniﬁcantly (p > 0.05) different from the negative control
(Table 3).
3.4. Micronucleus analysis
There was signiﬁcant increase (p < 0.05) in the frequencies of
micronucleated polychromatic erythrocyte formed in the bone
marrow cells of the treated rats (Fig. 2). The efﬂuent treatment con-
centrations; 5, 10, 20, 30 and 50 % induced 1.41, 2.0, 1.68, 4.0 and
6.55 folds increase respectively compared to the negative control.
3.5. Histopathological assessment of the liver and kidney
Fig. 3a–d presents the histopathological sections of the liver
from the treated and control rats. Section of the liver from the
negative control rats showed apparently normal pentagonal sec-
tions of the hepatocytes with a large spheroidal nucleus (Fig. 3a).
Histopathology of the liver from efﬂuent treated rats showed thin-
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Table  1
Physico-chemical characteristics and heavy metals detected in the pharmaceutical efﬂuent and national and international permissible standards.
Parameters Efﬂuent NESREAa USEPAb
pH 6.3 6.0–9.0 6.5–8.5
Nitrate 3.50 10 10
Ammonia 0.13 10 0.02
BODc 4.60 50 –
CODd 93.0 90 –
Phosphate 2.25 2.0 –
Chloride 16.0 250 250
Sulphate 31.0 250 250
Hardness 56.0 – 0–75
Alkalinity 405 150 2.0
TDSe 107.0 – –
Cu  0.99 0.5 1.3
Fe  0.60 – 0.3
Cd  BDL 9.02 0.05
Mn  0.30 0.02 0.05
As  BDL – 0.01
Ni  BDL 0.05 –
Cr  BDL 0.05 0.1
*All values are in mg/L except pH. BDL = below detectable limit.
a National Environmental Standards and Regulations Enforcement Agency (2009) Nigeria) maximum permissible limits for wastewater discharge.
b United State Environmental Protection Agency (2006). www.epa.gov/safewater/mcl.html
c Biochemical Oxygen Demand.
d Chemical Oxygen Demand.
e Total Dissolved Solid.
Table 2
Effects of pharmaceutical efﬂuent on serum biochemical parameters in Wistar rats.
Conc (%) SOD (U/mg) CAT (mol/mg) MDA  (nmol/ml) TB (mg/dL) DB (mg/dL) Creatinine (mg/dL)
DW 5.52 ± 0.90 0.14 ± 0.02 5.57 ± 1.35 0.17 ± 0.04 0.11 ± 0.02 0.81 ± 0.17
5  13.48 ± 8.57 0.24 ± 0.33* 10.95 ± 1.96* 0.28 ± 0.04* 0.12 ± 0.02 0.91 ± 0.12
10  12.89 ± 3.98 0.15 ± 0.01 8.27 ± 0.69 0.31 ± 0.07* 0.14 ± 0.05 1.06 ± 0.20*
20  21.08 ± 1.15* 0.15 ± 0.01 7.03 ± 0.34 0.48 ± 0.21* 0.20 ± 0.07 1.46 ± 0.08*
30  33.31 ± 5.96* 0.95 ± 0.31* 9.47 ± 4.82* 0.24 ± 0.11 0.13 ± 0.05 1.08 ± 0.21*
50  28.97 ± 4.98* 1.04 ± 0.33* 30.77 ± 6.80* 0.21 ± 0.05 0.13 ± 0.04 0.96 ± 0.08
CYP  5.96 ± 1.45 0.21 ± 0.04* 10.98 ± 2.47* 0.38 ± 0.04* 0.17 ± 0.02 0.91 ± 0.06
End point represents mean ± SD for 5 rats. Values are signiﬁcantly different; *p < 0.05; compared to negative control. SOD (superoxide dismutase), CAT (catalase), MDA
(malondialdehyde), TB (total bilirubin), DB (direct bilirubin). DW (Distilled Water); CYP (Cyclophosphamide (40 mg/Kg bwt).
Table  3
Hematological proﬁle of rats treated with pharmaceutical efﬂuent.
Conc (%) RBC (x106 L) HCT (%) HGB (g/dL) MCH  (pg) MCHC (g/dL) PLT (x106 L) WBC  (x103 L)
DW 7.22 ± 0.59 44.74 ± 2.23 11.16 ± 0.80 15.78 ± 0.24 23.24 ± 3.45 807.6 ± 119.0 11.92 ± 2.13
5  6.90 ± 0.39 43.96 ± 1.94 10.90 ± 0.48 15.68 ± 0.27 24.80 ± 0.53 551.8 ± 143.2 11.12 ± 2.44
10  6.81 ± 1.02 42.20 ± 7.74 10.62 ± 0.64 15.50 ± 0.19 24.36±1.11 510.6 ± 199.3 8.94 ± 1.66*
20  6.80 ± 0.45 42.92 ± 2.22 10.42 ± 0.86 14.98 ± 0.71 24.92 ± 0.62 533.8 ± 228.0* 8.98 ± 1.44*
30  6.85 ± 0.46 40.96 ± 2.71 10.38 ± 0.77 14.82 ± 0.37 25.34 ± 0.52 486.8 ± 178.3* 7.84 ± 1.96*
50  6.63 ± 0.15 39.78 ± 1.02 9.82 ± 0.30 14.32 ± 1.84 24.70 ± 0.64 435.5 ± 119.3* 7.74 ± 2.03*
CYP  6.65 ± 0.53 41.54 ± 2.35 9.62 ± 0.78 15.16 ± 0.61 24.26 ± 1.26 435.2 ± 176.4* 5.00 ± 2.85*
(p  = 0.514) (p = 0.3782) (p = 0.0637) (p = 0.7658) (p = 0.4495) (p = 0.0313) (p = 0.0454)
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cnd points represent mean ± SD for 5 rats. RBC (Red blood cell count); HGB (Hemoglo
ount);  MCH  (mean corpuscular hemoglobin); MCHC (mean corpuscular hemoglobi
iffer  signiﬁcantly (*p  < 0.05) from corresponding control using Dunnett’s multiple 
ing of the hepatocytic cords (cord atrophy) with moderate kuffer
ell hyperplasia (Fig. 3b). Also numerous and well spread vacuola-
ions and necrosis of the hepatocytes were common among the
0 and 50% treated rats (Fig. 3c). Multifocal inﬂammatory cells
nd congestions of the central vein were also observed (Fig. 3d).
ig. 4(a–d) presents the histopathological sections of the kid-
ey from efﬂuent treated and control rats. Apparently normal
istopathology of the cortex and medulla was observed in the
idney section of the negative control rat while some nephro-
oxic lesions were observed in the treated rats. These lesions
nclude marked congestions of the interstitial tissues (Fig. 4b),
wollen epithelium along with congestions of the renal interstitium
Fig. 4c). Vacuolar and necrotic changes of the tubular epithelium
ells and ﬁbroplastic proliferation were also observed in the kidneyncentration); HCT (Percentage Hematocrit); PLT (platelets); WBC  (White blood cell
centration); DW (Distilled water); CYP (Cyclophosphamide 40 mg/kg). Superscripts
oc test. DW – Distilled water.
of the efﬂuent treated rats (Fig. 4d). The frequency of the severity of
histopathological lesions in liver and kidney were increased accord-
ing to the efﬂuent concentrations in the exposed rats (Table 4).
4. Discussion
The analyzed heavy metals in the efﬂuent, except Zn, Mn,  Fe and
Cu, were lower than acceptable limits by national and international
regulatory authorities (Table 1), was not in agreement with previ-
ous studies in which the concentrations of toxic metals; Cd, Cr, Pb,
Ni, Zn and Cu, in nine pharmaceutical efﬂuents from Lagos, Nigeria
[1] and a pharmaceutical efﬂuent from Lote-Pershuram industrial
area, India [32], were above WHO  recommended maximum con-
centration level. It is noteworthy that studies have reported high
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Fig. 3. Sections of the liver from rat exposed to pharmaceutical efﬂuent (H&E, ×400). (a) liver from rat in the negative control group showing apparently normal hepatocytes.
(b)  thinning of the hepatocytic cord with moderate kuffer cell hyperplasia (arrow). (c) Vacuolations of the hepatocytes (arrow) and necrosis (N). (d) Multifocal inﬂammatory
cellular  (MI) and vacuolar changes in the hepatoctes along with congestion of the central vein (C).
F  ×400
m s (arro
V ion (FP
c
c
cig. 4. Sections of the kidney from rats exposed to pharmaceutical efﬂuent (H&E,
edullary section of the nephron. (b) Marked congestion of the renal blood vessel
acuolar  changes of the tubular epithelium cells (arrow) and ﬁbroplastic proliferatoncentrations of toxic metals and organic compounds at varying
oncentrations above standard permissible limits in pharmaceuti-
al efﬂuents [1,3,4,5,32].). (a) kidney from a negative control rat showing apparently normal cortical and
w). (c) Swollen epithelium with congestions of the renal interstitium (arrow). (d)
).Liver and kidney in mammalian system are the most sensitive
predictor of chemical toxicity that correlates well with histopathol-
ogy and serum biochemistry with little inter-animal variations [33].
As the major site of chemical transformation, these organs are
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Table  4
Severity of histological lesions in the liver and kidney of rats exposed to the pharmaceutical efﬂuent.
Concentrations (%) NC 5 10 20 30 50
Observed histological changes
LIVER
Hepatic vacuolation − + + + + + + + + + +
Thinning of hepatocytic cords − – – − + + +
Kuffer  cell hyperplasia − – + − + + +
Multifocal inﬂammation − + − − + + + + +
Congestion of hepatic blood vessels − − − + + + + + + +
Necrosis  − + + + + + + +
KIDNEY
Congestion of renal blood vessels − + + + ++ + + +
Swollen  tubular epithelium − − − − + + +
Necrotic changes − − − + + + + + +
Renal  vacuolar change − + + + + + + + +
NC – Negative control (distilled water).
Severity of the liver and kidney histological changes were assessed using the following scale:
−(change that was either absent or sporadic in all rats of a group).
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m(a change that was  found in a few animals of a group).
 +(a change that was relatively common in all animals of a group).
 + +(a change that was  very often found in all animals of a group).
rone to the toxic effects of chemicals. When cell membranes of
he hepatocytes are damaged, a number of cytoplasmic enzymes
re released into the circulatory system providing basis for clini-
al diagnosis. Serum AST and ALT are the most used biochemical
arkers of hepatocellular necrosis and are considered sensitive
ndicators of hepatic chemical induced injuries [34]. Signiﬁcant
ncrease in serum ALT and AST activities and concomitant increase
n total and direct bilirubin concentrations in the treated rats sug-
est acute hepatocellular damage due to the induction of necrosis
y the xenobiotics in the efﬂuent. Increase in lipid peroxidative
amage induced by the toxic metals and possibly unanalyzed
rganic constituents of the efﬂuent on the hepatocytes (necrosis),
ncreased cell membrane permeability to ALT and AST from the
ytoplasm into the blood circulation. Hepatic necrosis of the liver
ells and signiﬁcant increase in serum MDA  in the treated rats are
n support of this assertion. Serum creatinine concentration is a
iomarker of renal injury and the elevation of this biomarker is
sually associated with impairment of renal function [35]. Increase
n serum creatinine in the treated rats compared to the negative
ontrol suggests kidney damage possibly due to the depression of
lomerular ﬁltration rate and renal tubular cell injury by the xeno-
iotics present in the efﬂuent. The reports that e-waste leachate
reated mice [16] and landﬁll leachates treated rats [15] elicited
igniﬁcantly high concentrations of serum transaminases and cre-
tinine along with the induction of histopathological lesions are in
oncert with the observations herein.
Histological study provides the most reliable information on
he type of lesions induced by chemicals in tissues. It is also use-
ul in providing information on the toxic effects of xenobiotics
hat may  not lead to alterations in biochemical parameters [36].
he histopathological lesions observations in the liver (Fig. 3) and
idney (Fig. 4) of rats exposed to sub-lethal concentrations of
he pharmaceutical efﬂuent, corroborates the biochemical ﬁndings
uggesting liver and kidney dysfunctions induced by xenobiotics in
he efﬂuent [15]. The physico-chemical parameters analyzed in the
fﬂuent are known to modify metal toxicity and bioavailability [50].
t is possible that the high COD, TDS and more importantly alkalin-
ty of the efﬂuent modiﬁed toxicity of the metals (even at their low
oncentrations) leading to the observed genotoxicity and systemic
oxicity [51]. It is also known that the metals and possibly organic
ompounds (though not analyzed) in the efﬂuent acted in synergy
nd or antagonism to induce alterations in enzyme biochemistry,
iological molecules and cell membrane [16,37]. These alterations
ay  be attributed to increased cellular formation of oxidative stressvia creation of imbalance between reactive oxygen species (ROS)
and the antioxidant systems [38]. SOD activity is important in
preventing oxidative damage by scavenging and converting super-
oxide anions to hydrogen peroxides, while catalase causes the
decomposition of the hydrogen peroxide to protect tissues from
the actions of the highly reactive hydroxyl radicals [34]. During
ROS production, the activities of these enzymes may be altered
leading to the induction of pathological disorders and DNA damage
[39]. The signiﬁcant increase in the activities of SOD and CAT in the
treated rats suggests harmful effects of the constituents, mostly
the toxic metals, via excess undetoxiﬁed free radical formation.
These unscavenged free radicals similarly induced lipoperoxide
formation which caused lipid peroxidation in the cell membrane
(increase MDA  concentration) of the treated rats compared to the
negative control. Li et al. [40] similarly reported alterations in SOD
and CAT activities with concomitant change in MDA concentra-
tions in landﬁll leachate treated mice due to the toxic metals of
the leachate generated free radicals by autoxidation.
Hematological testing in rodents during toxicity and safety
evaluations is generally acknowledged as integral part of safety
assessment [30]. The tested efﬂuent induced reduction in RBC, HCT,
HGB, MCV, MCH, PLT and WBC  and increased MCHC concentra-
tions in the blood of the treated rats compared to the negative
control, suggests the hematotoxic effects of the constituents of the
efﬂuent. It is suggested that hematological changes are associated
with hematopathology and data from in vivo toxicological studies
in mammals is one of the most predictive measures for human risk
assessment [41]. The observed hematological alterations may  indi-
cate the effects of individual or interactive actions of the xenobiotics
in the efﬂuent on the hematopoietic tissues in the bone marrow
of the treated rats. This assertion is supported by the reports that
xenobiotics in landﬁll leachates [14], distillery soil leachate [42] and
textile dye efﬂuent [43] induced signiﬁcant alterations in hemato-
logical parameters of rats and mice, was due to the disturbance in
the hematopoiesis of the bone marrow system.
MN test is the most widely utilized test for the genotoxic and
mutagenic assessment of xenobiotics due to its technical simplic-
ity, less time consumption and ability to detect both clastogens
and aneugens [44]. Micronuclei (MN) are formed in addition to the
main nucleus in cells as a result of acentric fragments or lagging
chromosomes that failed to incorporate into either of the daughter
nuclei during cell division [44]. The signiﬁcant increase in MNPCE
observed in the bone marrow cells of the efﬂuent exposed rats
showed that the components of the efﬂuent are genotoxic, lead-
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ng to DNA damage. Xenobiotics in pharmaceutical efﬂuents are
nown mutagens and carcinogens that are capable of inducing
hromosomal damage may  increase genomic instability. Mn  and
e, observed in the efﬂuent, though are considered essential ele-
ents that play roles in normal enzyme activities that enhance
ell growth, but when in high concentrations due to chronic low
ose exposure, may  provoke DNA damage by binding to biologi-
ally sensitive molecules; DNA or forming dangerous free radicals
45]. The reports that pharmaceutical efﬂuent induced MNPCE and
bnormal sperm morphology in mice [8], (2009), and chromosome
berrations in Allium cepa and mice [8,22] are in agreement with
he ﬁndings herein and further supports that xenobiotics in the
fﬂuents are clastogens. The report of Alexandrov et al. [46] that Al
nd Fe interacted synergistically to induce DNA damage in human
eural (HN) cells via oxidative stress generation, further supports
he ﬁndings herein that the components of the efﬂuent probably
cted in synergy to elicit free radical formation which induced the
bserved MNPCE formation in the treated rats.
There are increasing reports on the role of oxidative stress
licited by mixture of xenobiotics present in leachates and efﬂuents
n the induction of abnormal cellular functions and pathologi-
al disorders [16,47]. Oxidative stress induced cell damage may
ccur via a number of mechanisms [48] and the damaged cells
ay  be eliminated either by programmed cell death (apoptosis)
r accidental cell death (necrosis). Efﬂuent induced cellular necro-
is and inﬂammation in the liver and kidney cells of the treated
ats may  be associated with the destruction of certain signal path-
ays in the cells and the disruption of mitochondrial functions via
nﬂammatory process [49]. This is the ﬁrst reports that showed that
harmaceutical efﬂuent altered SOD and CAT activities, and MDA
oncentration in rats. The induced alterations correlated with cel-
ular pathological lesions in the hepatocytes and kidney tubules,
ltered hematological indices, and increased MNPCE formation in
he bone marrow cells of treated rats. In conclusion, pharmaceuti-
al efﬂuent induced somatic mutation and systemic toxicity in rats
s associated with oxidative stress induction.
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